Please login to the form below

Not currently logged in
Email:
Password:

HBV

This page shows the latest HBV news and features for those working in and with pharma, biotech and healthcare.

Arbutus hit hard as new hep B drug fails on safety

Arbutus hit hard as new hep B drug fails on safety

HBV affects an estimated 350 million people worldwide, according to the US Centers for Disease Control and Prevention (CDC). ... in time – a fairly sizeable minority develops chronic HBV that resists drug treatment and can lead to cirrhosis and liver

Latest news

More from news
Approximately 2 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    Success in our clinical programs for flu, HPV and HBV vaccines could help shine a light on vaccines: currently a therapeutic modality that saves more lives per year than almost any

  • Deal Watch October 2018

    Product / Technology. Deal Type. Headline. ($). Arrowhead/. Janssen (J&J). Development &commercialisation of ARO‐HBV, based on. ... the TRiM platform, for chronic HBV infection. Licence. $3.7B. Endocyte /. Novartis. Radiopharmaceuticals and drug

  • Pharma deals in April 2015 Pharma deals in April 2015

    These are key markets for this product as more than 75% of all HCC cases occur in the APAC region, largely in association with chronic hepatitis B virus (HBV) infection.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics